樊均明. 循证临床治疗手册肾脏疾病 [M]. 北京:人民卫生出版社, 2008.148.
|
Kumagai H, Oda T, Ohshima N. Recent advance in kidney and hypertension research [J]. Nihon Jinzo Gakkai Shi, 2012(1):1.
|
陈绿娥. 缬沙坦治疗原发性高血压肾功能损害疗效观察 [J]. 现代中西医结合杂志, 2010, (21):2644.
|
Derosa G, Ferrari I, Cicero A F. Irbesartan and hydrochlorothiazide association in the treatment ofhypertension [J]. Current Vascular Pharmacology, 2009(2):120.
|
Xu B, Chiu J, Feng B. PARP activation and the alteration of vasoactive factors and extracellular matrix protein in retina and kidney in diabetes [J]. Diabetes/Metabolism Research and Review, 2008(5):404.
|
Imanishi M, Okada N, Konishi Y. Angiotensin Ⅱ receptor blockade reduces salt sensitivity of blood pressure through restoration of renal nitric oxide synthesis in patients with diabetic nephropathy [J]. Journal of the Renin-Angiotensin-Aldosterone System, 2012.
|
方利华, 张红霞. 缬沙坦治疗高血压合并早期糖尿病肾病 [J]. 中国现代药物应用, 2008(2):95.
|
Fogari R, Zoppi A. A drug safety evaluation of valsartan [J]. Expert Opinion Drug Safety, 2011(2):295.
|
瘳志松. 缬沙坦对原发性高血压病患者44例肾脏保护作用的1临床研究 [J]. 中外医学研究, 2010, (14):268.
|
刘红艺. 老年糖尿病患者的临床护理分析 [J]. 实用临床医药杂志, 2012, (14):33.doi: 10.3969/j.issn.1672-2353.2012.14.012.
|
曹晏防, 蔡危威, 张丽莉. 新诊断2型糖尿病患者微量白蛋白尿的患病率及危险因素分析 [J]. 实用临床医药杂志, 2012(7):104.doi: 10.3969/j.issn.1672-2353.2012.07.036.
|
李沛霖, 杨锐, 周勇. 糖尿病肾病患者糖化血清蛋白测定的意义 [J]. 南方医科大学学报, 2011(6):1093.
|
郑华, 屠燕, 马立勤. 心病患者经皮冠状动脉介入术后并发造影剂肾病的危险因素分析及防治策略探讨 [J]. 南方医科大学学报, 2011(7):1273.
|